MAM
SulaFest 2025 returns after five years with music, wine, and culture
Mumbai: Sula Vineyards is thrilled to announce the return of ‘SulaFest’, Asia’s favourite vineyard music festival, set for its 14th edition on 1-2 February 2025. After a five-year break, SulaFest is poised to offer an extraordinary mix of live music, premium wines, and rich cultural experiences amid the stunning scenery of Sula’s lush Nashik vineyards.
Sula Vineyards CEO, Rajeev Samant shared his anticipation: “We’re absolutely delighted to bring SulaFest back after five years. The festival has always embodied our love for wine, music, and community. This break has only amplified our enthusiasm to create an experience that not only honours the SulaFest legacy but elevates it to new heights. We can’t wait to welcome everyone back to Nashik for an unforgettable celebration.”
Since its inception, SulaFest has drawn audiences with performances by artists such as Lucky Ali, Divine, Amit Trivedi, and international acts like ‘Dub Inc.’ and ‘Gaudi’. Known for its lively atmosphere where music, dance, and wine intersect, SulaFest has become a highly anticipated event. Its comeback in 2025 is fuelled by popular demand from devoted fans.
The 2025 edition promises a diverse lineup, showcasing acclaimed musicians and new talents for an exceptional musical journey. Guests can look forward to interactive wine tastings led by top sommeliers, gourmet food experiences, and an artisanal marketplace. Attendees will enjoy Sula’s renowned wines, elevating their culinary adventure at the festival. SulaFest will now be held as a biennial event, allowing for more curated and elevated experiences.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
